 | • レポートコード：QFJ1-6036 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、治療用タンパク質＆経口ワクチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療用タンパク質、経口ワクチン）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・治療用タンパク質＆経口ワクチンの市場動向 ・企業の競争状況、市場シェア ・治療用タンパク質＆経口ワクチンの種類別市場規模と予測2016-2027（治療用タンパク質、経口ワクチン） ・治療用タンパク質＆経口ワクチンの用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・治療用タンパク質＆経口ワクチンの北米市場規模2016-2027（アメリカ、カナダ） ・治療用タンパク質＆経口ワクチンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・治療用タンパク質＆経口ワクチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・治療用タンパク質＆経口ワクチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・治療用タンパク質＆経口ワクチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Amgen、Biogen、Eli Lilly and Company、Roche、Johnson and Johnson、Merck、Novo Nordisk、Pfizer、Sanofi、Serum Institute of India、Emergent Biosolutions、TransAlgae、MigVax、Lumen Bioscience） ・結論 |
Therapeutic proteins are engineered in the laboratory for pharmaceutical use. They include non-covalent binders, enzymes and albumin and therefore have a wide range of treatment applications. Oral vaccines are biologically prepared products, which provide active acquired immunity to diseases. There are currently oral vaccines targeting cholera, polio, rotavirus, smallpox and yellow fever, among others. Oral vaccines comprise an agent resembling the disease-causing microorganism, such as a live attenuated or killed viral particle or the micro-organisms toxins or surface proteins.
Market Analysis and Insights: Global Therapeutic Proteins and Oral Vaccines Market
The global Therapeutic Proteins and Oral Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Therapeutic Proteins and Oral Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Therapeutic Proteins and Oral Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Therapeutic Proteins and Oral Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Therapeutic Proteins and Oral Vaccines market.
Global Therapeutic Proteins and Oral Vaccines Scope and Market Size
Therapeutic Proteins and Oral Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Proteins and Oral Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Therapeutic Proteins
Oral Vaccines
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
Amgen
Biogen
Eli Lilly and Company
Roche
Johnson and Johnson
Merck
Novo Nordisk
Pfizer
Sanofi
Serum Institute of India
Emergent Biosolutions
TransAlgae
MigVax
Lumen Bioscience
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Therapeutic Proteins
1.2.3 Oral Vaccines
1.3 Market by Application
1.3.1 Global Therapeutic Proteins and Oral Vaccines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Proteins and Oral Vaccines Market Perspective (2016-2027)
2.2 Therapeutic Proteins and Oral Vaccines Growth Trends by Regions
2.2.1 Therapeutic Proteins and Oral Vaccines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Therapeutic Proteins and Oral Vaccines Historic Market Share by Regions (2016-2021)
2.2.3 Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Regions (2022-2027)
2.3 Therapeutic Proteins and Oral Vaccines Industry Dynamic
2.3.1 Therapeutic Proteins and Oral Vaccines Market Trends
2.3.2 Therapeutic Proteins and Oral Vaccines Market Drivers
2.3.3 Therapeutic Proteins and Oral Vaccines Market Challenges
2.3.4 Therapeutic Proteins and Oral Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Proteins and Oral Vaccines Players by Revenue
3.1.1 Global Top Therapeutic Proteins and Oral Vaccines Players by Revenue (2016-2021)
3.1.2 Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Players (2016-2021)
3.2 Global Therapeutic Proteins and Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Therapeutic Proteins and Oral Vaccines Revenue
3.4 Global Therapeutic Proteins and Oral Vaccines Market Concentration Ratio
3.4.1 Global Therapeutic Proteins and Oral Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Proteins and Oral Vaccines Revenue in 2020
3.5 Therapeutic Proteins and Oral Vaccines Key Players Head office and Area Served
3.6 Key Players Therapeutic Proteins and Oral Vaccines Product Solution and Service
3.7 Date of Enter into Therapeutic Proteins and Oral Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Proteins and Oral Vaccines Breakdown Data by Type
4.1 Global Therapeutic Proteins and Oral Vaccines Historic Market Size by Type (2016-2021)
4.2 Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Type (2022-2027)
5 Therapeutic Proteins and Oral Vaccines Breakdown Data by Application
5.1 Global Therapeutic Proteins and Oral Vaccines Historic Market Size by Application (2016-2021)
5.2 Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Therapeutic Proteins and Oral Vaccines Market Size (2016-2027)
6.2 North America Therapeutic Proteins and Oral Vaccines Market Size by Type
6.2.1 North America Therapeutic Proteins and Oral Vaccines Market Size by Type (2016-2021)
6.2.2 North America Therapeutic Proteins and Oral Vaccines Market Size by Type (2022-2027)
6.2.3 North America Therapeutic Proteins and Oral Vaccines Market Size by Type (2016-2027)
6.3 North America Therapeutic Proteins and Oral Vaccines Market Size by Application
6.3.1 North America Therapeutic Proteins and Oral Vaccines Market Size by Application (2016-2021)
6.3.2 North America Therapeutic Proteins and Oral Vaccines Market Size by Application (2022-2027)
6.3.3 North America Therapeutic Proteins and Oral Vaccines Market Size by Application (2016-2027)
6.4 North America Therapeutic Proteins and Oral Vaccines Market Size by Country
6.4.1 North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2016-2021)
6.4.2 North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Therapeutic Proteins and Oral Vaccines Market Size (2016-2027)
7.2 Europe Therapeutic Proteins and Oral Vaccines Market Size by Type
7.2.1 Europe Therapeutic Proteins and Oral Vaccines Market Size by Type (2016-2021)
7.2.2 Europe Therapeutic Proteins and Oral Vaccines Market Size by Type (2022-2027)
7.2.3 Europe Therapeutic Proteins and Oral Vaccines Market Size by Type (2016-2027)
7.3 Europe Therapeutic Proteins and Oral Vaccines Market Size by Application
7.3.1 Europe Therapeutic Proteins and Oral Vaccines Market Size by Application (2016-2021)
7.3.2 Europe Therapeutic Proteins and Oral Vaccines Market Size by Application (2022-2027)
7.3.3 Europe Therapeutic Proteins and Oral Vaccines Market Size by Application (2016-2027)
7.4 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country
7.4.1 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2016-2021)
7.4.2 Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size (2016-2027)
8.2 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Type
8.2.1 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Type (2016-2027)
8.3 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Application
8.3.1 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Application (2016-2027)
8.4 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region
8.4.1 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Therapeutic Proteins and Oral Vaccines Market Size (2016-2027)
9.2 Latin America Therapeutic Proteins and Oral Vaccines Market Size by Type
9.2.1 Latin America Therapeutic Proteins and Oral Vaccines Market Size by Type (2016-2021)
9.2.2 Latin America Therapeutic Proteins and Oral Vaccines Market Size by Type (2022-2027)
9.2.3 Latin America Therapeutic Proteins and Oral Vaccines Market Size by Type (2016-2027)
9.3 Latin America Therapeutic Proteins and Oral Vaccines Market Size by Application
9.3.1 Latin America Therapeutic Proteins and Oral Vaccines Market Size by Application (2016-2021)
9.3.2 Latin America Therapeutic Proteins and Oral Vaccines Market Size by Application (2022-2027)
9.3.3 Latin America Therapeutic Proteins and Oral Vaccines Market Size by Application (2016-2027)
9.4 Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country
9.4.1 Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country (2016-2021)
9.4.2 Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size (2016-2027)
10.2 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Type
10.2.1 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Type (2016-2027)
10.3 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Application
10.3.1 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Application (2016-2027)
10.4 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country
10.4.1 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Therapeutic Proteins and Oral Vaccines Introduction
11.1.4 Abbott Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Therapeutic Proteins and Oral Vaccines Introduction
11.2.4 Amgen Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Biogen
11.3.1 Biogen Company Details
11.3.2 Biogen Business Overview
11.3.3 Biogen Therapeutic Proteins and Oral Vaccines Introduction
11.3.4 Biogen Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
11.3.5 Biogen Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Details
11.4.2 Eli Lilly and Company Business Overview
11.4.3 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Introduction
11.4.4 Eli Lilly and Company Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
11.4.5 Eli Lilly and Company Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Therapeutic Proteins and Oral Vaccines Introduction
11.5.4 Roche Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Company Details
11.6.2 Johnson and Johnson Business Overview
11.6.3 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Introduction
11.6.4 Johnson and Johnson Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
11.6.5 Johnson and Johnson Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Therapeutic Proteins and Oral Vaccines Introduction
11.7.4 Merck Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Novo Nordisk
11.8.1 Novo Nordisk Company Details
11.8.2 Novo Nordisk Business Overview
11.8.3 Novo Nordisk Therapeutic Proteins and Oral Vaccines Introduction
11.8.4 Novo Nordisk Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
11.8.5 Novo Nordisk Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Therapeutic Proteins and Oral Vaccines Introduction
11.9.4 Pfizer Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Therapeutic Proteins and Oral Vaccines Introduction
11.10.4 Sanofi Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
11.10.5 Sanofi Recent Development
11.11 Serum Institute of India
11.11.1 Serum Institute of India Company Details
11.11.2 Serum Institute of India Business Overview
11.11.3 Serum Institute of India Therapeutic Proteins and Oral Vaccines Introduction
11.11.4 Serum Institute of India Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
11.11.5 Serum Institute of India Recent Development
11.12 Emergent Biosolutions
11.12.1 Emergent Biosolutions Company Details
11.12.2 Emergent Biosolutions Business Overview
11.12.3 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Introduction
11.12.4 Emergent Biosolutions Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
11.12.5 Emergent Biosolutions Recent Development
11.13 TransAlgae
11.13.1 TransAlgae Company Details
11.13.2 TransAlgae Business Overview
11.13.3 TransAlgae Therapeutic Proteins and Oral Vaccines Introduction
11.13.4 TransAlgae Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
11.13.5 TransAlgae Recent Development
11.14 MigVax
11.14.1 MigVax Company Details
11.14.2 MigVax Business Overview
11.14.3 MigVax Therapeutic Proteins and Oral Vaccines Introduction
11.14.4 MigVax Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
11.14.5 MigVax Recent Development
11.15 Lumen Bioscience
11.15.1 Lumen Bioscience Company Details
11.15.2 Lumen Bioscience Business Overview
11.15.3 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Introduction
11.15.4 Lumen Bioscience Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
11.15.5 Lumen Bioscience Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Therapeutic Proteins and Oral Vaccines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Therapeutic Proteins
Table 3. Key Players of Oral Vaccines
Table 4. Global Therapeutic Proteins and Oral Vaccines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Therapeutic Proteins and Oral Vaccines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Therapeutic Proteins and Oral Vaccines Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Therapeutic Proteins and Oral Vaccines Market Share by Regions (2016-2021)
Table 8. Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Therapeutic Proteins and Oral Vaccines Market Share by Regions (2022-2027)
Table 10. Therapeutic Proteins and Oral Vaccines Market Trends
Table 11. Therapeutic Proteins and Oral Vaccines Market Drivers
Table 12. Therapeutic Proteins and Oral Vaccines Market Challenges
Table 13. Therapeutic Proteins and Oral Vaccines Market Restraints
Table 14. Global Therapeutic Proteins and Oral Vaccines Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Therapeutic Proteins and Oral Vaccines Market Share by Players (2016-2021)
Table 16. Global Top Therapeutic Proteins and Oral Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Proteins and Oral Vaccines as of 2020)
Table 17. Ranking of Global Top Therapeutic Proteins and Oral Vaccines Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Therapeutic Proteins and Oral Vaccines Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Therapeutic Proteins and Oral Vaccines Product Solution and Service
Table 21. Date of Enter into Therapeutic Proteins and Oral Vaccines Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Therapeutic Proteins and Oral Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Type (2016-2021)
Table 25. Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Therapeutic Proteins and Oral Vaccines Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Application (2016-2021)
Table 29. Global Therapeutic Proteins and Oral Vaccines Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Therapeutic Proteins and Oral Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Therapeutic Proteins and Oral Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Therapeutic Proteins and Oral Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Therapeutic Proteins and Oral Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Therapeutic Proteins and Oral Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Therapeutic Proteins and Oral Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Therapeutic Proteins and Oral Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Therapeutic Proteins and Oral Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Therapeutic Proteins and Oral Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Therapeutic Proteins and Oral Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Therapeutic Proteins and Oral Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Therapeutic Proteins and Oral Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Therapeutic Proteins and Oral Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Therapeutic Proteins and Oral Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Therapeutic Proteins and Oral Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Therapeutic Proteins and Oral Vaccines Product
Table 64. Abbott Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Amgen Company Details
Table 67. Amgen Business Overview
Table 68. Amgen Therapeutic Proteins and Oral Vaccines Product
Table 69. Amgen Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021) & (US$ Million)
Table 70. Amgen Recent Development
Table 71. Biogen Company Details
Table 72. Biogen Business Overview
Table 73. Biogen Therapeutic Proteins and Oral Vaccines Product
Table 74. Biogen Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021) & (US$ Million)
Table 75. Biogen Recent Development
Table 76. Eli Lilly and Company Company Details
Table 77. Eli Lilly and Company Business Overview
Table 78. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product
Table 79. Eli Lilly and Company Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021) & (US$ Million)
Table 80. Eli Lilly and Company Recent Development
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche Therapeutic Proteins and Oral Vaccines Product
Table 84. Roche Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021) & (US$ Million)
Table 85. Roche Recent Development
Table 86. Johnson and Johnson Company Details
Table 87. Johnson and Johnson Business Overview
Table 88. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product
Table 89. Johnson and Johnson Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021) & (US$ Million)
Table 90. Johnson and Johnson Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Therapeutic Proteins and Oral Vaccines Product
Table 94. Merck Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021) & (US$ Million)
Table 95. Merck Recent Development
Table 96. Novo Nordisk Company Details
Table 97. Novo Nordisk Business Overview
Table 98. Novo Nordisk Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021) & (US$ Million)
Table 99. Novo Nordisk Recent Development
Table 100. Pfizer Company Details
Table 101. Pfizer Business Overview
Table 102. Pfizer Therapeutic Proteins and Oral Vaccines Product
Table 103. Pfizer Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021) & (US$ Million)
Table 104. Pfizer Recent Development
Table 105. Sanofi Company Details
Table 106. Sanofi Business Overview
Table 107. Sanofi Therapeutic Proteins and Oral Vaccines Product
Table 108. Sanofi Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021) & (US$ Million)
Table 109. Sanofi Recent Development
Table 110. Serum Institute of India Company Details
Table 111. Serum Institute of India Business Overview
Table 112. Serum Institute of India Therapeutic Proteins and Oral Vaccines Product
Table 113. Serum Institute of India Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021) & (US$ Million)
Table 114. Serum Institute of India Recent Development
Table 115. Emergent Biosolutions Company Details
Table 116. Emergent Biosolutions Business Overview
Table 117. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product
Table 118. Emergent Biosolutions Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021) & (US$ Million)
Table 119. Emergent Biosolutions Recent Development
Table 120. TransAlgae Company Details
Table 121. TransAlgae Business Overview
Table 122. TransAlgae Therapeutic Proteins and Oral Vaccines Product
Table 123. TransAlgae Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021) & (US$ Million)
Table 124. TransAlgae Recent Development
Table 125. MigVax Company Details
Table 126. MigVax Business Overview
Table 127. MigVax Therapeutic Proteins and Oral Vaccines Product
Table 128. MigVax Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021) & (US$ Million)
Table 129. MigVax Recent Development
Table 130. Lumen Bioscience Company Details
Table 131. Lumen Bioscience Business Overview
Table 132. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product
Table 133. Lumen Bioscience Revenue in Therapeutic Proteins and Oral Vaccines Business (2016-2021) & (US$ Million)
Table 134. Lumen Bioscience Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Therapeutic Proteins and Oral Vaccines Market Share by Type: 2020 VS 2027
Figure 2. Therapeutic Proteins Features
Figure 3. Oral Vaccines Features
Figure 4. Global Therapeutic Proteins and Oral Vaccines Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Therapeutic Proteins and Oral Vaccines Report Years Considered
Figure 9. Global Therapeutic Proteins and Oral Vaccines Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Therapeutic Proteins and Oral Vaccines Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Therapeutic Proteins and Oral Vaccines Market Share by Regions: 2020 VS 2027
Figure 12. Global Therapeutic Proteins and Oral Vaccines Market Share by Regions (2022-2027)
Figure 13. Global Therapeutic Proteins and Oral Vaccines Market Share by Players in 2020
Figure 14. Global Top Therapeutic Proteins and Oral Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Proteins and Oral Vaccines as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Therapeutic Proteins and Oral Vaccines Revenue in 2020
Figure 16. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Type (2016-2021)
Figure 17. Global Therapeutic Proteins and Oral Vaccines Revenue Market Share by Type (2022-2027)
Figure 18. North America Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Therapeutic Proteins and Oral Vaccines Market Share by Type (2016-2027)
Figure 20. North America Therapeutic Proteins and Oral Vaccines Market Share by Application (2016-2027)
Figure 21. North America Therapeutic Proteins and Oral Vaccines Market Share by Country (2016-2027)
Figure 22. United States Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Therapeutic Proteins and Oral Vaccines Market Share by Type (2016-2027)
Figure 26. Europe Therapeutic Proteins and Oral Vaccines Market Share by Application (2016-2027)
Figure 27. Europe Therapeutic Proteins and Oral Vaccines Market Share by Country (2016-2027)
Figure 28. Germany Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Therapeutic Proteins and Oral Vaccines Market Share by Region (2016-2027)
Figure 38. China Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Therapeutic Proteins and Oral Vaccines Market Share by Type (2016-2027)
Figure 46. Latin America Therapeutic Proteins and Oral Vaccines Market Share by Application (2016-2027)
Figure 47. Latin America Therapeutic Proteins and Oral Vaccines Market Share by Country (2016-2027)
Figure 48. Mexico Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Share by Country (2016-2027)
Figure 54. Turkey Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Therapeutic Proteins and Oral Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
Figure 58. Amgen Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
Figure 59. Biogen Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
Figure 60. Eli Lilly and Company Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
Figure 62. Johnson and Johnson Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
Figure 64. Novo Nordisk Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
Figure 67. Serum Institute of India Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
Figure 68. Emergent Biosolutions Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
Figure 69. TransAlgae Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
Figure 70. MigVax Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
Figure 71. Lumen Bioscience Revenue Growth Rate in Therapeutic Proteins and Oral Vaccines Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
治療ワクチンのグローバル市場調査 2019年 The global Therapeutic Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Therapeutic Vaccines volume and value at global level, regional level and company level. From a global perspective, th…- 治療ワクチンのグローバル市場調査 2019年 The global Therapeutic Vaccines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Therapeutic Vaccines volume and value at global level, regional level and company level. From a global perspective, th…
- 世界の副鼻腔治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sinus Therapeutic Drug Market The global Sinus Therapeutic Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…
- 経口ワクチンのグローバル市場2021 Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery …
- コレラワクチンオーラルライブのグローバル市場調査 2019年 The global Cholera Vaccines Oral Live market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cholera Vaccines Oral Live volume and value at global level, regional level and company level. From a global per…